AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 16, 2023
Alzheimer’s disease is often thought of as a condition that only affects the elderly. But around 3.9 million people worldwide aged 30-64 live with young-onset Alzheimer’s disease – a form of dementia in which symptoms appear before the age of 65.
BioSpace
JULY 16, 2023
Following disappointing topline data, BridgeBio’s acoramidis has scored a late-stage win in transthyretin amyloid cardiomyopathy, leading to significant survival and quality of life benefits.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuroBlog - Aurous Healthcare Clinical Trials blog
JULY 16, 2023
At least seven more pharma companies and a federation of pharma manufacturers have approached the Delhi High Court against the Central Government’s order in the beginning of June prohibiting manufacturing, distribution and sale of 14 fixed dose combinations (FDCs) licensed prior to the year 1988.
BioSpace
JULY 16, 2023
For over three years, no interest has accrued on federal student loans and no payments were required. Soon, mandatory payments will resume, leaving workers with less money in the bank.
JAMA Internal Medicine
JULY 16, 2023
This randomized clinical trial aims to determine whether a direct oral penicillin challenge is noninferior to the standard of care of penicillin skin testing followed by an oral challenge in patients with a low-risk penicillin allergy.
BioSpace
JULY 16, 2023
The Swiss pharma is expanding its neuroscience pipeline with an upfront $500 million payment to DTx Pharma and additional payments of up to $500 million upon completion of certain milestones.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
BioSpace
JULY 16, 2023
The Federal Trade Commission is asking for more information regarding Pfizer's planned $43 billion acquisition of Seagen, according to the latter’s Securities and Exchange Commission filing on Friday.
Drug Patent Watch
JULY 16, 2023
Annual Drug Patent Expirations for VIJOICE Vijoice is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting… The post New patent for Novartis drug VIJOICE appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
JULY 16, 2023
The 2023 Alzheimer’s Association International Conference will feature further analyses of the recent traditionally approved Leqembi and a highly anticipated update on Eli Lilly’s donanemab.
Drug Patent Watch
JULY 16, 2023
Annual Drug Patent Expirations for NUEDEXTA Nuedexta is a drug marketed by Avanir Pharms and is included in one NDA. It is available from two suppliers. There are two patents… The post New patent expiration for Avanir Pharms drug NUEDEXTA appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
BioSpace
JULY 16, 2023
Bringing new drugs to the market costs billions of dollars. It could not be done without investments by both the NIH and biopharma companies.
Drug Patent Watch
JULY 16, 2023
[
BioSpace
JULY 16, 2023
After beginning July with a splash in the Alzheimer's space, the FDA is expected to make three decisions during the next two weeks; two for cancer and one for a viral skin disease.
pharmaphorum
JULY 16, 2023
First Wave faces choppy waters with cystic fibrosis drug Phil.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioSpace
JULY 16, 2023
Part B of the study, cleared to proceed in Canada, remains on hold in the U.S. due to findings from non-clinical chronic toxicology studies.
JAMA Internal Medicine
JULY 16, 2023
This study compares performance on free-response clinical reasoning examinations of first- and second-year medical students vs 2 models of a popular chatbot.
pharmaphorum
JULY 16, 2023
Lilly bulks up in obesity with $1.93bn Versanis buy Phil.
JAMA Internal Medicine
JULY 16, 2023
This prognostic study assesses the ability of a chatbot to write a history of present illness compared with senior internal medicine residents.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Drug Patent Watch
JULY 16, 2023
This chart shows the drugs with the most patents in Sweden. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Sweden? appeared first on DrugPatentWatch - Make Better Decisions.
BioSpace
JULY 16, 2023
The U.S. regulator Monday approved the Beyfortus single-dose monoclonal antibody, developed jointly by the two companies, for the pediatric prevention of respiratory syncytial virus.
Expert insights. Personalized for you.
166 
Let's personalize your content